US Physicalrapy Earnings Estimate

USPH Stock  USD 86.94  0.60  0.69%   
The next projected EPS of US Physicalrapy is estimated to be 0.65885 with future projections ranging from a low of 0.64 to a high of 0.6725. US Physicalrapy's most recent 12-month trailing earnings per share (EPS TTM) is at 2.37. Please be aware that the consensus of earnings estimates for US Physicalrapy is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
US Physicalrapy is projected to generate 0.65885 in earnings per share on the 31st of December 2025. US Physicalrapy earnings estimates show analyst consensus about projected US Physicalrapy EPS (Earning Per Share). It derives the highest and the lowest estimates based on US Physicalrapy's historical volatility. Many public companies, such as US Physicalrapy, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

US Physicalrapy Revenue Breakdown by Earning Segment

By analyzing US Physicalrapy's earnings estimates, investors can diagnose different trends across US Physicalrapy's analyst sentiment over time as well as compare current estimates against different timeframes. As of now, US Physicalrapy's Gross Profit Margin is decreasing as compared to previous years. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

US Physicalrapy Earnings Estimation Breakdown

The calculation of US Physicalrapy's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of US Physicalrapy is estimated to be 0.65885 with the future projection ranging from a low of 0.64 to a high of 0.6725. Please be aware that this consensus of annual earnings estimates for US Physicalrapy is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.66
0.64
Lowest
Expected EPS
0.65885
0.67
Highest

US Physicalrapy Earnings Projection Consensus

Suppose the current estimates of US Physicalrapy's value are higher than the current market price of the US Physicalrapy stock. In this case, investors may conclude that US Physicalrapy is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and US Physicalrapy's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
793.09%
0.66
0.65885
2.37

US Physicalrapy Earnings History

Earnings estimate consensus by US Physicalrapy analysts from Wall Street is used by the market to judge US Physicalrapy's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only US Physicalrapy's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

US Physicalrapy Quarterly Gross Profit

36.87 Million

As of now, US Physicalrapy's Price Earnings To Growth Ratio is increasing as compared to previous years. The current Common Stock Shares Outstanding is estimated to decrease to about 13 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 19.8 M.
Hype
Prediction
LowEstimatedHigh
85.0187.0088.99
Details
Intrinsic
Valuation
LowRealHigh
78.2598.46100.45
Details
7 Analysts
Consensus
LowTargetHigh
95.85105.33116.92
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of USPH assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards US Physicalrapy. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving US Physicalrapy's stock price in the short term.

US Physicalrapy Earnings per Share Projection vs Actual

Actual Earning per Share of US Physicalrapy refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering US Physicalrapy predict the company's earnings will be in the future. The higher the earnings per share of US Physicalrapy, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

US Physicalrapy Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as US Physicalrapy, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of US Physicalrapy should always be considered in relation to other companies to make a more educated investment decision.

USPH Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact US Physicalrapy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-11
2025-09-300.670.66-0.01
2025-08-06
2025-06-300.70.810.1115 
2025-05-05
2025-03-310.45180.480.0282
2025-02-26
2024-12-310.69650.51-0.186526 
2024-11-05
2024-09-300.680.690.01
2024-08-13
2024-06-300.820.73-0.0910 
2024-05-07
2024-03-310.560.51-0.05
2024-02-28
2023-12-310.570.590.02
2023-11-07
2023-09-300.620.620.0
2023-08-08
2023-06-300.750.760.01
2023-05-03
2023-03-310.550.590.04
2023-02-22
2022-12-310.570.580.01
2022-11-02
2022-09-300.560.580.02
2022-08-04
2022-06-300.950.9-0.05
2022-05-05
2022-03-310.630.650.02
2022-02-24
2021-12-310.690.720.03
2021-11-04
2021-09-300.780.850.07
2021-08-05
2021-06-300.730.960.2331 
2021-05-06
2021-03-310.470.640.1736 
2021-02-25
2020-12-310.830.850.02
2020-11-05
2020-09-300.510.850.3466 
2020-08-06
2020-06-30-0.180.851.03572 
2020-05-21
2020-03-310.40.3-0.125 
2020-02-27
2019-12-310.690.64-0.05
2019-11-07
2019-09-300.710.710.0
2019-08-08
2019-06-300.810.810.0
2019-05-02
2019-03-310.60.660.0610 
2019-03-07
2018-12-310.630.710.0812 
2018-11-01
2018-09-300.580.640.0610 
2018-08-02
2018-06-300.680.730.05
2018-05-03
2018-03-310.560.560.0
2018-03-08
2017-12-310.470.490.02
2017-11-02
2017-09-300.490.510.02
2017-08-03
2017-06-300.590.590.0
2017-06-07
2017-03-310.470.480.01
2017-03-02
2016-12-310.470.46-0.01
2016-11-03
2016-09-300.490.46-0.03
2016-08-04
2016-06-300.550.570.02
2016-05-05
2016-03-310.390.430.0410 
2016-03-03
2015-12-310.470.480.01
2015-11-05
2015-09-300.480.47-0.01
2015-08-06
2015-06-300.580.48-0.117 
2015-05-07
2015-03-310.350.34-0.01
2015-03-05
2014-12-310.40.410.01
2014-11-06
2014-09-300.420.430.01
2014-08-07
2014-06-300.440.520.0818 
2014-05-08
2014-03-310.30.27-0.0310 
2014-03-06
2013-12-310.350.32-0.03
2013-11-07
2013-09-300.40.38-0.02
2013-08-08
2013-06-300.420.41-0.01
2013-05-09
2013-03-310.330.31-0.02
2013-03-07
2012-12-310.330.340.01
2012-11-08
2012-09-300.380.390.01
2012-08-09
2012-06-300.440.41-0.03
2012-05-03
2012-03-310.340.380.0411 
2012-03-08
2011-12-310.280.290.01
2011-11-03
2011-09-300.360.380.02
2011-08-04
2011-06-300.410.410.0
2011-05-05
2011-03-310.270.310.0414 
2011-03-03
2010-12-310.250.280.0312 
2010-11-04
2010-09-300.310.330.02
2010-08-05
2010-06-300.360.380.02
2010-05-06
2010-03-310.230.250.02
2010-03-04
2009-12-310.20.19-0.01
2009-11-05
2009-09-300.240.260.02
2009-08-06
2009-06-300.310.310.0
2009-05-07
2009-03-310.20.230.0315 
2009-03-05
2008-12-310.20.19-0.01
2008-11-06
2008-09-300.220.21-0.01
2008-08-07
2008-06-300.230.240.01
2008-05-08
2008-03-310.20.20.0
2008-03-06
2007-12-310.180.210.0316 
2007-11-08
2007-09-300.180.180.0
2007-08-02
2007-06-300.20.20.0
2007-05-03
2007-03-310.150.160.01
2007-03-16
2006-12-310.150.180.0320 
2006-11-02
2006-09-300.160.160.0
2006-08-01
2006-06-300.180.180.0
2006-05-04
2006-03-310.180.12-0.0633 
2006-03-02
2005-12-310.190.14-0.0526 
2005-10-27
2005-09-300.180.20.0211 
2005-08-02
2005-06-300.20.230.0315 
2005-04-28
2005-03-310.150.170.0213 
2005-03-03
2004-12-310.150.150.0
2004-10-27
2004-09-300.180.14-0.0422 
2004-07-29
2004-06-300.160.20.0425 
2004-04-29
2004-03-310.130.130.0
2004-03-04
2003-12-310.110.120.01
2003-10-30
2003-09-300.140.150.01
2003-07-31
2003-06-300.180.180.0
2003-04-30
2003-03-310.160.15-0.01
2003-02-27
2002-12-310.160.170.01
2002-11-08
2002-09-300.150.160.01
2002-08-01
2002-06-300.170.180.01
2002-05-01
2002-03-310.180.16-0.0211 
2001-08-02
2001-06-300.110.140.0327 
2001-03-09
2000-12-310.090.10.0111 
2000-11-08
2000-09-300.080.10.0225 
2000-08-14
2000-06-300.070.090.0228 
2000-05-15
2000-03-310.060.080.0233 
2000-02-28
1999-12-310.060.060.0
1999-11-10
1999-09-300.060.060.0
1999-08-05
1999-06-300.050.060.0120 
1998-11-13
1998-09-300.040.040.0
1998-08-05
1998-06-300.050.050.0
1998-06-26
1998-03-310.040.040.0
1998-03-17
1997-12-310.030.060.03100 
1997-11-07
1997-09-300.040.070.0375 
1997-08-07
1997-06-300.060.060.0
1997-05-13
1997-03-310.030.040.0133 
1997-03-19
1996-12-310.040.040.0
1996-11-06
1996-09-300.040.050.0125 

About US Physicalrapy Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of US Physicalrapy earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current US Physicalrapy estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as US Physicalrapy fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings261.4 M274.4 M
Retained Earnings Total Equity258.1 M158.3 M
Earnings Yield 0.02  0.02 
Price Earnings Ratio 45.45  47.73 
Price Earnings To Growth Ratio 1.33  1.39 

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is there potential for Health Care Providers & Services market expansion? Will USPH introduce new products? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.236
Dividend Share
1.79
Earnings Share
2.37
Revenue Per Share
49.547
Quarterly Revenue Growth
0.173
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, US Physicalrapy's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.